Risk Of Developing Liver Cancer After HCV Treatment

Friday, March 24, 2017

Healio Updates Non-Alcoholic Fatty Liver Disease (NAFLD) - Non-alcoholic steatohepatitis (NASH)

Non-Alcoholic Fatty Liver Disease (NAFLD) - Non-alcoholic steatohepatitis (NASH)
VIDEO: Physician discusses upcoming noninvasive modalities, treatments for NASH
In this exclusive video from Emerging Trends in Non-Alcoholic Fatty Liver Disease, Zobair M. Younossi, MD, MPH, FAASLD, chairman of the department of medicine at Inova Fairfax Hospital and vice president of research at Inova Health System, discusses topic highlights from the meeting, particularly steatohepatitis and future treatments.

VIDEO: Debate continues NAFLD treatment clinical trials’ construction
WASHINGTON — In this exclusive video from Emerging Trends in Non-Alcoholic Fatty Liver Disease, Kris V. Kowdley, MD, FAASLD, of the Swedish…

VIDEO: Hispanic patients at higher risk for developing fatty liver disease
“There are substantial differences in the likelihood of having fatty liver disease across various ethnicities,” Sanyal said. “People of Hispanic origin, or particularly those who are not of European origin, have a high prevalence of fatty liver disease. Not only do they have more fatty liver disease, but it can progress faster to cirrhosis, and this is closely linked to the prevalence of obesity and type 2 diabetes in this population.”

Imaging modalities provide confirmative results of NAFLD, NASH
Imaging modalities, such as magnetic resonance imagining and magnetic resonance elastography, provided significantly confirmative…

NASH recurrence does not hinder liver transplantation success
“In long-term studies, the highest frequency of graft loss related to recurrence of NASH appears to be around 5%. This is in stark contrast with hepatitis C ... with a 3rd of patients with HCV dying, requiring retransplantation or having cirrhosis due to recurrence of HCV within 5 years,” Michael R. Charlton, MD, of the department of medicine at the University of Chicago, said during his presentation. “Knowing that NASH itself is not an important cause of transplant graft failure and death, those other causes we looked at earlier — cardiovascular disease, neoplasia, renal insufficiency — these are much more common causes of death following liver transplantation, particularly in patients with fatty liver disease.”

Children diagnosed with non-alcoholic fatty liver disease between the ages 7 and 12 years presented with worse steatohepatitis and other factors than…

View all updates, here....

No comments:

Post a Comment